Inventor · disambiguated record
Patrick Van De Velde
Also filed as: VAN DE VELDE PATRICK
21 granted patents·88 citations·filing 1990–2002
94Inventor score
Files withAVENTIS PHARMA SA9ROUSSEL UCLAF7HOECHST MARION ROUSSEL INC3HOESCHST MARION ROUSSEL1ROUSSEL HOECHST MARION1
Top patents by PatentIndex Score
21 records- 0171US6596885B219-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositionsAVENTIS PHARMA SA·Filed 2001·Granted Jul 22, 2003·4 cites·1 claims
- 0270US5494907A11-β substituted-19-nor steroidsROUSSEL UCLAF·Filed 1994·Granted Feb 27, 1996·19 cites·11 claims
- 0367US6482813B1Steroids substituted at the 11-position, process for their preparation, their use as medicament and the pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2000·Granted Nov 19, 2002·2 cites·9 claims
- 0464US6399766B24-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2001·Granted Jun 4, 2002·1 cites·4 claims
- 0554US5705494AAnti-estrogenic activity of IIβ-substituted-19-NOR SteroidsROUSSEL UCLAF·Filed 1995·Granted Jan 6, 1998·9 cites·3 claims
- 0654US5556845A11-β substituted-19-nor steroidsROUSSEL UCLAF·Filed 1995·Granted Sep 17, 1996·9 cites·7 claims
- 0753US5149696A19→nor→steroidsROUSSEL UCLAF·Filed 1990·Granted Sep 22, 1992·8 cites·11 claims
- 0852US6541464B2Steroids substituted at the 11-position, process for their preparation, their use as medicament and the pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2002·Granted Apr 1, 2003·0 cites·5 claims
- 0952US5679788A11 beta-substituted-19 nor-steroidsROUSSEL UCLAF·Filed 1996·Granted Oct 21, 1997·9 cites·1 claims
- 1051US6472382B24-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2000·Granted Oct 29, 2002·0 cites·9 claims
- 1151US6462211B14-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2000·Granted Oct 8, 2002·0 cites·3 claims
- 1249US5290771A19-nor-steroidsROUSSEL UCLAF·Filed 1992·Granted Mar 1, 1994·6 cites·11 claims
- 1346US5981516AMethod of treating menopause or perimenopauseHOECHST MARION ROUSSEL INC·Filed 1997·Granted Nov 9, 1999·5 cites·5 claims
- 1445US6566542B217-Halogenated 19-nor steroids, preparation process and intermediates, use as medicaments and the pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2002·Granted May 20, 2003·0 cites·2 claims
- 1545US6239121B14- Halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing sameHOECHST MARION ROUSSEL INC·Filed 1998·Granted May 29, 2001·4 cites·11 claims
- 1642US6207657B1Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing themHOECHST MARION ROUSSEL INC·Filed 1997·Granted Mar 27, 2001·3 cites·6 claims
- 1741US6790971B119-Nor-steroidsAVENTIS PHARMA SA·Filed 1995·Granted Sep 14, 2004·4 cites·2 claims
- 1834US6423700B117-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing sameAVENTIS PHARMA SA·Filed 1999·Granted Jul 23, 2002·2 cites·10 claims
- 1933US6281204B119-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositionsROUSSEL HOECHST MARION·Filed 1992·Granted Aug 28, 2001·1 cites·13 claims
- 2032US6011026AMethod of treating menopause or perimenopauseHOESCHST MARION ROUSSEL·Filed 1999·Granted Jan 4, 2000·2 cites·7 claims
- 2131US5707982A19-nor-steroidsROUSSEL UCLAF·Filed 1993·Granted Jan 13, 1998·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →